High-Throughput Platform for Fast-Acting Covalent Protein Therapies
Using this new platform, researchers developed a covalent antagonist targeting PD-L1, termed IB101, which was found to form a defined binding pocket that precisely positions the active moiety in a reactive conformation. The post High-Throughput Platform for Fast-Acting Covalent Protein Therapies appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.